Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Genentech
Genentech
Genentech to eliminate 474 positions
Beckers Hospital Review
Wed, 07/29/20 - 11:53 pm
Genentech
layoffs
COVID-19
Genentech's Tecentriq-Avastin Combo Fails to Hit Primary Endpoint in Ovarian Cancer
BioSpace
Mon, 07/13/20 - 12:15 pm
Genentech
Roche
clinical trials
Tecentriq
ovarian cancer
I-O blockbusters from Merck, BMS and more linked to poor COVID-19 outcomes: study
Fierce Pharma
Thu, 06/25/20 - 08:36 pm
immuno-oncology
checkpoint inhibitors
Merck
Bristol-Meyers Squibb
COVID-19
Keytruda
Opidvo
Yervoy
Genentech
Tecentriq
AstraZeneca
Imfinzi
Roche's Checkpoint Inhibitor Hits the Mark in Early Triple-Negative Breast Cancer Study
BioSpace
Thu, 06/18/20 - 08:38 pm
Roche
Genentech
Tecentriq
triple negative breast cancer
clinical trials
Celgene
Abraxane
Denali scoots past a setback with barely a scratch, quickly calling up a backup Alzheimer’s player on the bench
Endpoints
Wed, 06/10/20 - 11:00 am
Denali Therapeutics
Genentech
DNL747
Genentech’s Phase III Trial Yields Positive Results and Hope for Patients with Wet AMD
BioSpace
Wed, 05/27/20 - 11:56 pm
Genentech
clinical trials
wet age-related macular degeneration
ranibizumab
Genentech posts long-term data on near-approval Soliris rival
Fierce Biotech
Fri, 05/22/20 - 10:46 am
Genentech
satralizumab
Soliris
Alexion
NMOSD
3 Roche Companies Hope to Make Clinical Trials More Efficient
Medical Devices and Diagnostics Industry
Tue, 05/19/20 - 11:19 pm
Flatiron Health
Foundation Medicine
Genentech
Roche
genomics
clinical trials
lung cancer
FDA approves Genentech’s Tecentriq as first-line monotherapy for certain people with metastatic NSCLC
Pharmaceutical Business Review
Tue, 05/19/20 - 10:44 am
Genentech
Roche
Tecentriq
FDA
metastatic non-small cell lung cancer
Genentech lures Regev from Broad Institute to lead research and early development
Fierce Biotech
Mon, 05/11/20 - 10:31 am
Genentech
Broad Institute
R&D
Aviv Regev
Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma
Fierce Pharma
Fri, 04/17/20 - 11:30 pm
Roche
Genentech
Novo Nordisk
AbbVie
Fortune
employees
Experts float Roche stroke drug Activase as potential COVID-19 therapy
Fierce Pharma
Fri, 03/27/20 - 08:20 pm
Roche
Genentech
Activase
stroke
COVID-19
Roche Tests Arthritis Drug Actemra for COVID-19 Pneumonia
Motley Fool
Mon, 03/23/20 - 11:33 pm
Roche
Genentech
Actemra
FDA
clinical trials
COVID-19
Genentech's Esbriet Granted Breakthrough Therapy Designation for uILD
BioSpace
Wed, 03/4/20 - 10:47 am
Genentech
Esbriet
uILD
breakthrough therapy
FDA
Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact
Fierce Biotech
Tue, 02/25/20 - 10:18 am
Roche
Genentech
Bicycle Therapeutics
R&D
immuno-oncology
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
Stat
Tue, 02/4/20 - 10:04 am
biotech
Jeff Leiden
Vertex Pharmaceuticals
Herb Boyer
Bob Swanson
Genentech
Amgen
George Rathmann
Gordon Binder
Roche's Tecentriq fails trial in form of urothelial cancer
Reuters
Fri, 01/24/20 - 10:08 am
Roche
Genentech
clinical trials
Tecentriq
urothelial cancer
bladder cancer
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
Arcus and Roche Partner on Colorectal and Pancreatic Cancer Trials
BioSpace
Thu, 12/19/19 - 12:45 pm
Roche
Genentech
Arcus Biosciences
clinical trials
colorectal cancer
pancreatic cancer
AB928
Roche's flu med Xofluza drives drug resistance and may be a bad choice for kids, study says
Fierce Pharma
Wed, 11/27/19 - 12:34 pm
Roche
Genentech
Xofluza
pediatrics
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »